Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins

Experimental Hematology

Volumn 38, Issue 6, 2010, Pages 481-488

  Ng, Ming Him James ^a   Ng, Ray Kit ^a   Kong, Cheuk Ting ^a   Jin, Dong Yan ^a   Chan, Li Chong ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; HYBRID PROTEIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MIXED LINEAGE LEUKEMIA AF4 HYBRID PPROTEIN; MIXED LINEAGE LEUKEMIA AF5Q31 HYBRID PPROTEIN; MIXED LINEAGE LEUKEMIA CDCREL HYBRID PPROTEIN; MIXED LINEAGE LEUKEMIA LAF4 HYBRID PPROTEIN; MIXED LINEAGE LEUKEMIA MSF HYBRID PPROTEIN; MIXED LINEAGE LEUKEMIA SEPTIN 6 HYBRID PPROTEIN; MUTANT PROTEIN; ONCOPROTEIN; RAS PROTEIN; SEPTIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE REARRANGEMENT; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; LEUKEMOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REPORTER GENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ETS-DOMAIN PROTEIN ELK-1; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HELA CELLS; HUMANS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PHOSPHORYLATION; PROTEIN KINASES; RAS PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 77952957383     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.03.014     Document Type: Article

References (22)

1. Daser A., Rabbitts T.H. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin Cancer Biol 2005, 15:175-188.
2. Meyer C., Schneider B., Jakob S., et al. The MLL recombinome of acute leukemias. Leukemia 2006, 20:777-784.
3. So C.W., Cleary M.L. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood 2003, 101:633-639.
4. Zeisig B.B., Schreiner S., Garcia-Cuellar M.P., Slany R.K. Transcriptional activation is a key function encoded by MLL fusion partners. Leukemia 2003, 17:359-365.
5. So C.W., Lin M., Ayton P.M., Chen E.H., Cleary M.L. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell 2003, 4:99-110.
6. Martin M.E., Milne T.A., Bloyer S., et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 2003, 4:197-207.
7. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev 2003, 3:11-22.
8. Wittwer F., van der Straten A., Keleman K., Dickson B.J., Hafen E. Lilliputian: an AF4/FMR2-related protein that controls cell identity and cell growth. Development 2001, 128:791-800.
9. Mahgoub N., Parker R.I., Hosler M.R., et al. RAS mutations in pediatric leukemias with MLL gene rearrangements. Genes Chromosomes Cancer 1998, 21:270-275.
10. Shih L.Y., Liang D.C., Fu J.F., et al. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia 2006, 20:218-223.
11. So C.W., Caldas C., Liu M.M., et al. EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc Natl Acad Sci U S A 1997, 94:2563-2568.
12. Yam J.W., Jin D.Y., So C.W., Chan L.C. Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein. Blood 2004, 103:1445-1453.
13. Ching Y.P., Chan S.F., Jeang K.T., Jin D.Y. The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol 2006, 8:717-724.
14. Kong C.T., Sham M.H., So C.W., Cheah K.S., Chen S.J., Chan L.C. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice. Leukemia 2006, 20:1829-1839.
15. Thomas M., Gessner A., Vornlocher H.P., Hadwiger P., Greil J., Heidenreich O. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Blood 2005, 106:3559-3566.
16. Dick J.E. Stem cells: self-renewal writ in blood. Nature 2003, 423:231-233.
17. Dick J.E. Acute myeloid leukemia stem cells. Ann N Y Acad Sci 2005, 1044:1-5.
18. Wang J.C., Dick J.E. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005, 15:494-501.
19. Nakanishi H., Nakamura T., Canaani E., Croce C.M. ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias. Proc Natl Acad Sci U S A 2007, 104:14442-14447.
20. Luscher-Firzlaff J., Gawlista I., Vervoorts J., et al. The human trithorax protein hASH2 functions as an oncoprotein. Cancer Res 2008, 68:749-758.
21. Ono R., Kumagai H., Nakajima H., et al. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation. Leukemia 2009, 23. 2197-1209.
22. Kim W.I., Matise I., Diers M.D., Largaespada D.A. RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia. Blood 2009, 113:1086-1096.